Mutual Funds

Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Equity | Very High | Equity - Sectoral Fund - Pharma & Health Care

10.49 +0.04
NAV(₹) as on 6/7/2026

0.36%
1D

4.28%
1Y

-
3Y

-
5Y

Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio:	Launch Date: 27 Jun 2025
Exit Load: NIL upto 10% of units and 1% for remaining units on or before 1Y, Nil after 1Y	AUM: ₹ 544.17 Crs
Lock-in: Nil	Investing Style: Large Growth
Portfolio Price To Book Value: 9.25	Min. Investment: SIP : ₹ 500.00 Lumpsum : ₹ 1,000.00
Scheme Benchmark: NA
Fund Manager: Sanjay Chawla ,Rohan Korde

FUND OBJECTIVE

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

LATEST ASSET & PORTFOLIO ALLOCATION		Others		Equity
as on 31/5/2026		2.59 %		97.41 %

TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.

9.09 %

Lupin Ltd.

5.83 %

Laurus Labs Ltd.

5.76 %

Abbott India Ltd.

5.43 %

Torrent Pharmaceuticals Ltd.

5.27 %

Ipca Laboratories Ltd.

5.18 %

Apollo Hospitals Enterprise Ltd.

4.66 %

JB Chemicals & Pharmaceuticals Ltd.

4.38 %

Fortis Healthcare Ltd.

4.27 %

Astrazeneca Pharma India Ltd.

4.12 %

See All Holding

ALLOCATION BY MARKET CAP (Equity)

ALLOCATION BY RATING (Debt & Others)

No Data

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs

68.51 %

Hospital & Healthcare Servic

17.51 %

Insurance

6.05 %

Retailing

1.65 %

IT - Software

1.54 %

See All Sectors

PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year	2025-26
NAV (31/3/2026)	9.10
Net Assets (Rs Crores)	51,519.31
Scheme Returns(%)(Absolute)	-8.96
B'mark Returns(%)(Absolute)	NA
Category Rank	98/120

RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details	Inception Date	Aum(₹ Crs)	1Y	3Y	5Y	Since Inception
Kotak Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.16 +0.16	11/12/2023	₹ 560.17	19.15%	-	-	20.60%
Quant Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.36 +0.03	17/7/2023	₹ 372.5	8.93%	-	-	20.40%
HDFC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 20.70 +-0.02	4/10/2023	₹ 2,362.44	20.98%	-	-	30.37%
WOC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.15 +-0.06	6/2/2024	₹ 664.02	17.98%	-	-	21.95%
PGIM India Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.43 +0.09	6/12/2024	₹ 95.49	14.53%	-	-	8.87%
Bajaj Finserv Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.05 +0.03	27/12/2024	₹ 332.52	13.06%	-	-	6.75%
Baroda BNP Paribas Health and Wellness Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.49 +0.04	27/6/2025	₹ 544.17	4.28%	-	-	4.80%
Bandhan Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.87 +0.13	28/11/2025	₹ 310.92	-	-	-	8.66%
ITI Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.63 +0.01	8/11/2021	₹ 237.99	5.63%	19.38%	-	12.94%
Nippon India Pharma Fund(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 564.84 +0.62	5/6/2004	₹ 8,635.75	8.05%	20.86%	12.92%	20.03%